Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
cancer immunotherapy
3
×
deals
3
×
genentech
3
×
life sciences
national blog main
national top stories
new york blog main
san francisco blog main
agenus
boulder/denver blog main
boulder/denver top stories
celgene
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
investing
johnson & johnson
national
new york top stories
pain drug
pfizer
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
startups
tanezumab
texas blog main
texas top stories
What
bio
companies
drug
roundup
acquire
agreed
alzheimer’s
approved
big
billion
broad
confidence
didn’t
different
digital
disease
epidemic
fail
fatty
fda
foundation
frenzied
gain
gene
genentech
growing
increases
known
latest
led
liver
medicine
merck
momentum
morning
nash
news
panels
pay
pays
Language
Current search:
genentech
×
deals
×
" cancer immunotherapy "
×
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine